Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Rare

Recent news which mentions Rare

< Previous 1 2 3 4 5 Next >
Recap: Ultragenyx Pharmaceutical Q4 Earnings
Tickers RARE
Tags Benzinga Market News Earnings
From Benzinga
The Latest Analyst Ratings For Ultragenyx Pharmaceutical
Tickers RARE
Tags RARE Analyst Ratings BZI/AAR
From Benzinga
Earnings Scheduled For February 15, 2024
Tickers AEM AGIO AL ALKS
Tags COIN DASH BPMC
From Benzinga
Preview: Ultragenyx Pharmaceutical's Earnings
Tickers RARE
Tags Earnings BZI/EP Market News
From Benzinga
4 Analysts Have This To Say About Ultragenyx Pharmaceutical
Tickers RARE
Tags BZI/AAR Analyst Ratings RARE
From Benzinga
Expert Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags Market News Benzinga Analyst Ratings
From Benzinga
Analyst Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags Benzinga Market News RARE
From Benzinga
Earnings Outlook For Ultragenyx Pharmaceutical
Tickers RARE
Tags RARE Earnings BZI/EP
From Benzinga
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Tickers AHG ALPP BCEL BEAM
Tags RTO ENSC GRIN
From Benzinga
AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
Tickers AAL BMI CJET LNN
Tags Markets Movers CJET
From Benzinga
Why Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Tickers ADD AHG ALB ALBT
Tags SFT ADD IBKR
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tickers ATHX BIO BIOC EIGR
Tags RARE XGN EIGR
From Benzinga
Why Is Mereo BioPharma Stock Trading Higher Today?
Tickers MREO RARE
Tags why it's moving Benzinga Equities
From Benzinga
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags RARE BZI/AAR Analyst Ratings
From Benzinga
Earnings Scheduled For August 3, 2023
Tickers MYGN MYPS NET NGVC
Tags STEM NSTG OCN
From Benzinga
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags BZI/AAR Analyst Ratings RARE
From Benzinga
Meta’s stock deemed a high-conviction buy at Citi, as strategy remains ‘underappreciated’
Tickers AIG META RARE TW
Tags META AIG TW
From MarketWatch
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags RARE Analyst Ratings BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023
Tickers AAPL ABNB AEP AGEN
Tags AMCX Benzinga CMS
From Benzinga
Apple To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Tuesday
Tickers AAPL ADBE CSTL CXM
Tags DG analyst forecasts GTLB
From Benzinga
Why Ultragenyx Pharma Stock Is Trading Higher Premarket Today
Tickers MREO RARE
Tags Penny Stocks Briefs Market News
From Benzinga
Ultragenyx Pharmaceutical's Return On Capital Employed Insights
Tickers RARE
Tags RARE BZI/ROCE Market News
From Benzinga
Ultragenyx Pharmaceutical: Q1 Earnings Insights
Tickers RARE
Tags Benzinga Market News Earnings
From Benzinga
A Preview Of Ultragenyx Pharmaceutical's Earnings
Tickers RARE
Tags Earnings BZI/EP Market News
From Benzinga
Expert Ratings for Ultragenyx Pharmaceutical
Tickers RARE
Tags Market News Benzinga RARE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023
Tickers ACI BKU BRBR CCEP
Tags Downgrades BZI/Ratings COIN
From Benzinga
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
Tickers BEAM CRSP EDIT LEGN
Tags BEAM NTLA RARE
From InvestorPlace
Where Ultragenyx Pharmaceutical Stands With Analysts
Tickers RARE
Tags RARE Analyst Ratings BZI/AAR
From Benzinga
Earnings Scheduled For February 16, 2023
Tickers AEL AEM AL ALE
Tags WE CGNX USFD
From Benzinga
Earnings Preview: Ultragenyx Pharmaceutical
Tickers RARE
Tags RARE Benzinga Market News
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.